Press Room


Protein A Resins Market worth over $900mn by 2024

Protein A Resins Market size is set to exceed USD 900 million by 2024; as per a new research report by Global Market Insights, Inc.
 

Protein A resins are crucial and are broadly used as purification and separation materials owing to high resolution, across the biopharmaceutical industry. They exploit the chemical and physical variances among biomolecules for separation of antibodies by immunoprecipitation and antibody purification. Growing diagnostic and therapeutic applications of monoclonal antibodies will be the major driver for protein A resins market size.
 

High selectivity and improved antibody yield coupled with ease of operation in large and small scale antibody purification and immunoprecipitation will further drive the protein A resins market growth. Chromatography with these has several advantages as a separation method, over conventional techniques like solvent extraction, crystallization, and distillation. For instance, it can separate all the components of a multicomponent biochemical mixture without demanding a detailed foreknowledge of the number, identity, or relative quantities of the materials present in the mixture.

 

Request Sample Buy NowInquiry Before Buying

 

U.S.  market growth will continue to dominate other regions due to presence of well-established infrastructure for clinical trials.  Recombinant protein A resins market will grow at significant CAGR of around 8% during the forecast period owing to the wealth of techniques and products used for their expression and purification. Contract research organizations (CROs) provide modified solutions for monoclonal antibody and recombinant protein production from mammalian cell culture. The segment accounted for second highest revenue share of around 15%. CROs also offer large-scale protein production and virus production, making it suitable for pharmaceutical and biotechnology companies as well as academic institutions to outsource processes.
 

Browse key industry insights spread across 127 pages with 123 market data tables & around 8 figures & charts from the report, “Protein A Resins Market Size By Application (Immunoprecipitation, Antibody Purification), By Product (Natural protein A, Recombinant Protein A), By Matrix (Agarose, Glass/Silica Gel, Organic Polymer), By End Use (Biopharmaceutical, Clinical Research, Academic Research, CRO), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, Russia, Poland, Japan, China, India, Australia, Argentina, Brazil, Mexico, South Africa, UAE, Saudi Arabia, Qatar, Kuwait, Egypt), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/protein-a-resins-market
 

In 2015, Spain protein A resins market size was over USD 25 million, increasing investments by public and private companies in the development of biosimilars and increasing demand for biosimilar products are the significant factors driving the market for monoclonal antibodies and eventually Spain market growth.
 

Asia Pacific protein A resins market will grow at highest CAGR of over 8.5%, favorable government policies, dynamic infrastructure development will attract international companies to set-up manufacturing plants in the region and availability of skilled professionals at affordable costs. The region has emerged as a preferred destination for contract research organizations and various biopharmaceutical companies to establish business.
 

Japan protein A resins market accounted for over 40% share, as its healthcare infrastructure is experiencing noteworthy transformation. The government is strategically planning a regulatory system in which public and private companies will contribute to develop novel biosimilar products.
 

India antibody purification market has witnessed notable growth in recent years, which could continue in the vicinity of 10%, with factors such as increasing research into the development monoclonal antibodies, driving protein A resins market growth.
 

Major industry companies include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
 

Protein A resins market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2012 to 2024, for the following segments:

Protein A Resins Market By Application

  • Immunoprecipitation
  • Antibody Purification  

By Product

  • Natural protein A
  • Recombinant protein A

By Matrix

  • Agarose-based matrix
  • Glass or silica gel-based matrix
  • Organic polymer-based matrix

By End Use

  • Biopharmaceutical companies
  • Clinical research laboratories
  • Academic Research Institutes
  • Contract Research Organizations
     

The above information is provided on a regional and country basis for the following:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • Russia
    • Poland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • Kuwait
    • Egypt